Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients

One of the greatest concerns in Chagas' disease is the absence of reliable methods for the evaluation of chemotherapy efficacy in treated patients. The tests available to evaluate cure after the specific treatment are the complement-mediated lysis (CoML) and flow cytometry tests, but they are n...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Meira, Wendell S. F., Galvão, Lúcia M. C., Gontijo, Eliane D., Machado-Coelho, George L. L., Norris, Karen A., Chiari, Egler
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Microbiology 2004
Θέματα:
Parasitology
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC344465/
https://ncbi.nlm.nih.gov/pubmed/14766840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.42.2.707-712.2004
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια